Ironwood Pharmaceuticals
IRWD
IRWD
250 hedge funds and large institutions have $2.03B invested in Ironwood Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 94 increasing their positions, 88 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 88
1.37% less ownership
Funds ownership: 110.78% → 109.41% (-1.4%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
250
Holding in Top 10
1
Calls
$1.6M
Puts
$28K
Top Buyers
| 1 | +$27.1M | |
| 2 | +$17.6M | |
| 3 | +$17.4M | |
| 4 |
Two Sigma Advisers
New York
|
+$14.9M |
| 5 |
BlackRock
New York
|
+$9.95M |
Top Sellers
| 1 | -$57.5M | |
| 2 | -$15.7M | |
| 3 | -$12.4M | |
| 4 |
BM
Bridger Management
New York
|
-$9.49M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$8.42M |